This article is more than 5 years old. Information may no longer be current.
Light therapy for wrinkles, FDA approval of Siliq top dermatology reads for week
Click Here to Manage Email Alerts
Study results finding that low-level light therapy significantly and safely improved facial skin wrinkles was among the most-read articles of the past week on Healio.com/Dermatology.
Other widely read articles included the FDA’s approval of Siliq for treating moderate-to-severe plaque psoriasis:
Low-level light therapy improved periocular wrinkles
Low-level light therapy significantly and safely improved facial skin wrinkles, according to study results published in Dermatologic Surgery.
Researchers in Korea conducted a prospective double-blind study of 52 women aged between 30 and 65 years with more than grade 3 lateral periocular wrinkles. Read more
FDA approves Siliq for treating psoriasis
The FDA announced that it has approved Siliq as treatment for moderate-to-severe plaque psoriasis.
Siliq (brodalumab, Valeant Pharmaceuticals) is administered by injection and is intended for patients who are candidates for systemic therapy or phototherapy and have failed to respond or have stopped responding to other systemic therapies, according to a press release. Read more
Allergan to acquire Zeltiq, CoolSculpting body contouring system
Allergan announced in a press release today that it has agreed to acquire Zeltiq Aesthetics for $56.50 per share or $2.475 billion.
The acquisition will include Zeltiq’s CoolSculpting System, the sales leader in the cash pay body contouring segment of medical aesthetics, according to the release. Read more
Acne treatments should be selected according to age, gender, ethnicity
MIAMI — Understanding the effects of age, gender and ethnicity when treating a patient for acne can inform the best approach to treatment, according to a speaker here.
“When you sit down with an acne patient, I do believe you need to spend a lot of time with these patients and it’s not just a little trite condition,” Diane S. Berson, MD, said at South Beach Symposium 2017. Read more
FDA warns of rare, serious allergic reactions with skin antiseptic chlorhexidine gluconate
The FDA recently issued a warning to patients and health care professionals that rare but serious allergic reactions have been reported with skin antiseptic products containing chlorhexidine gluconate.
The agency reported in a safety announcement that while rare, the number of reports of serious allergic reactions to the products have increased over the past several years. Read more